HeartX - Excerpts & Experiences from Experts

Ambulatory blood pressure monitoring (ABPM) is a crucial tool for diagnosing primary and secondary hypertension, predicting cardiovascular disease and mortality, and identifying white-coat and masked subtypes. It provides a 24-hour account of a patient's state, with a diagnostic threshold of ≥130/80 mmHg over 24 hours. ABPM offers better prognosis of hypertension-mediated organ damage, is more...

Ambulatory blood pressure monitoring (ABPM) is a crucial tool for diagnosing primary and secondary hypertension, predicting cardiovascular disease and mortality, and identifying white-coat and masked subtypes. It provides a 24-hour account of a patient's state, with a diagnostic threshold of ≥130/80 mmHg over 24 hours. ABPM offers better prognosis of hypertension-mediated organ damage, is more...

Angiotensin receptor blockers (ARBs) and telmisartan have a renoprotective effect on renal endothelial function, preventing progression from microalbuminuria to macroalbuminuria, slowing the decline in glomerular filtration rate, and reducing proteinuria in overt nephropathy. ARB/ACEi combination therapy with SGLT2 inhibitors could achieve better control of blood pressure and estimated glomerular...

Angiotensin receptor blockers (ARBs) and telmisartan have a Reno protective effect on renal endothelial function, preventing progression from microalbuminuria to macroalbuminuria, slowing the decline in glomerular filtration rate, and reducing proteinuria in overt nephropathy. ARB/ACEi combination therapy with SGLT2 inhibitors could achieve better control of blood pressure and estimated glomerular...

Triple therapy is a combination of three antihypertensive medications to lower blood pressure, providing comprehensive and effective control. It is recommended for patients with stage 2 hypertension, high cardiovascular risk, chronic kidney disease, heart failure, or diabetes. Healthcare professionals should evaluate patients' health, monitor blood pressure, and adjust medication regimens base...

High blood pressure (HBP) is a symptomless "silent killer" that can lead to serious health problems. To reduce high blood pressure, lifestyle changes can be made such as eating healthy, exercising, quitting smoking, cutting down on alcohol, getting a good night's sleep, reducing stress, and monitoring blood pressure at home. These changes can help reduce the risk of heart disease, st...

Triple therapy is a combination of three antihypertensive medications to lower blood pressure, providing comprehensive and effective control. It is recommended for patients with stage 2 hypertension, high cardiovascular risk, chronic kidney disease, heart failure, or diabetes. Healthcare professionals should evaluate patients' health, monitor blood pressure, and adjust medication regimens base...

High blood pressure (HBP) is a symptomless "silent killer" that can lead to serious health problems. To reduce high blood pressure, lifestyle changes can be made such as eating healthy, exercising, quitting smoking, cutting down on alcohol, getting a good night's sleep, reducing stress, and monitoring blood pressure at home. These changes can help reduce the risk of heart disease, st...

Angiotensin receptor blockers (ARBs) and telmisartan have a renoprotective effect on renal endothelial function, preventing progression from microalbuminuria to macroalbuminuria, slowing the decline in glomerular filtration rate, and reducing proteinuria in overt nephropathy. ARB/ACEi combination therapy with SGLT2 inhibitors could achieve better control of blood pressure and estimated glomerular...

Angiotensin receptor blockers (ARBs) and telmisartan have a renoprotective effect on renal endothelial function, preventing progression from microalbuminuria to macroalbuminuria, slowing the decline in glomerular filtration rate, and reducing proteinuria in overt nephropathy. ARB/ACEi combination therapy with SGLT2 inhibitors could achieve better control of blood pressure and estimated glomerular...

Angiotensin receptor blockers (ARBs) and telmisartan have a Reno protective effect on renal endothelial function, preventing progression from microalbuminuria to macroalbuminuria, slowing the decline in glomerular filtration rate, and reducing proteinuria in overt nephropathy. ARB/ACEi combination therapy with SGLT2 inhibitors could achieve better control of blood pressure and estimated glomerular...

Cilnidipine is a novel, effective, and safe CCB that inhibits L-type and N-type calcium channels, regulating cardiac function. It is recommended for combination therapy in diabetic hypertensive patients to reduce cardiovascular and renal risks. ARBs, like telmisartan and losartan, are effective in reducing cardiovascular risk factors and renal complications. Cilnidipine's reno-protective and c...

Triple therapy is a combination of three antihypertensive medications to lower blood pressure, providing comprehensive and effective control. It is recommended for patients with stage 2 hypertension, high cardiovascular risk, chronic kidney disease, heart failure, or diabetes. Healthcare professionals should evaluate patients' health, monitor blood pressure, and adjust medication regimens base...

Triple therapy is a combination of three antihypertensive medications to lower blood pressure, providing comprehensive and effective control. It is recommended for patients with stage 2 hypertension, high cardiovascular risk, chronic kidney disease, heart failure, or diabetes. Healthcare professionals should evaluate patients' health, monitor blood pressure, and adjust medication regimens base...

Ambulatory blood pressure monitoring (ABPM) is a crucial tool for diagnosing primary and secondary hypertension, predicting cardiovascular disease and mortality, and identifying white-coat and masked subtypes. It provides a 24-hour account of a patient's state, with a diagnostic threshold of ≥130/80 mmHg over 24 hours. ABPM offers better prognosis of hypertension-mediated organ damage, is more...

Angiotensin receptor blockers (ARBs) and telmisartan have a Reno protective effect on renal endothelial function, preventing progression from microalbuminuria to macroalbuminuria, slowing the decline in glomerular filtration rate, and reducing proteinuria in overt nephropathy. ARB/ACEi combination therapy with SGLT2 inhibitors could achieve better control of blood pressure and estimated glomerular...

Triple therapy is a combination of three antihypertensive medications to lower blood pressure, providing comprehensive and effective control. It is recommended for patients with stage 2 hypertension, high cardiovascular risk, chronic kidney disease, heart failure, or diabetes. Healthcare professionals should evaluate patients' health, monitor blood pressure, and adjust medication regimens base...

Ambulatory blood pressure monitoring (ABPM) is a crucial tool for diagnosing primary and secondary hypertension, predicting cardiovascular disease and mortality, and identifying white-coat and masked subtypes. It provides a 24-hour account of a patient's state, with a diagnostic threshold of ≥130/80 mmHg over 24 hours. ABPM offers better prognosis of hypertension-mediated organ damage, is more...

Ambulatory blood pressure monitoring (ABPM) is a crucial tool for diagnosing primary and secondary hypertension, predicting cardiovascular disease and mortality, and identifying white-coat and masked subtypes. It provides a 24-hour account of a patient's state, with a diagnostic threshold of ≥130/80 mmHg over 24 hours. ABPM offers better prognosis of hypertension-mediated organ damage, is more...

Angiotensin receptor blockers (ARBs) and telmisartan have a Reno protective effect on renal endothelial function, preventing progression from microalbuminuria to macroalbuminuria, slowing the decline in glomerular filtration rate, and reducing proteinuria in overt nephropathy. ARB/ACEi combination therapy with SGLT2 inhibitors could achieve better control of blood pressure and estimated glomerular...

Angiotensin receptor blockers (ARBs) and telmisartan have a Reno protective effect on renal endothelial function, preventing progression from microalbuminuria to macroalbuminuria, slowing the decline in glomerular filtration rate, and reducing proteinuria in overt nephropathy. ARB/ACEi combination therapy with SGLT2 inhibitors could achieve better control of blood pressure and estimated glomerular...

Ambulatory blood pressure monitoring (ABPM) is a crucial tool for diagnosing primary and secondary hypertension, predicting cardiovascular disease and mortality, and identifying white-coat and masked subtypes. It provides a 24-hour account of a patient's state, with a diagnostic threshold of ≥130/80 mmHg over 24 hours. ABPM offers better prognosis of hypertension-mediated organ damage, is more...

Angiotensin receptor blockers (ARBs) and telmisartan have a reno protective effect on renal endothelial function, preventing progression from microalbuminuria to macroalbuminuria, slowing the decline in glomerular filtration rate, and reducing proteinuria in overt nephropathy. ARB/ACEi combination therapy with SGLT2 inhibitors could achieve better control of blood pressure and estimated glomerular...

Angiotensin receptor blockers (ARBs) are widely used antihypertensive drugs that help reduce the cardiovascular and cerebrovascular risks and renal complications in patients with hypertension. Telmisartan has been shown to improve renal endothelial function, prevent progression from microalbuminuria to macroalbuminuria, slow the decline in glomerular filtration rate, and reduce proteinuria in over...

As per WHO, nearly 63% of total deaths in India are due to non-communicable diseases, of which 27% are attributed to CVD which affects 45% of people in the 40-69 age group. Raised blood pressure is among the most important risk factors for CVDs which remains poorly controlled due to low awareness about hypertension, lack of appropriate care through primary care, and poor follow-up of the patients....